MST1 deletion has been proved to improve β-cell survival and insulin secretion in models of diabetes induced by streptozotocin (STZ) or HFD, and a combination of HFD and streptozotocin (HFS/STZ) [105, 112, 113]. Here, INS is linked to diabetes mellitus.